NCT Number: NCT00435058
Visual Function Changes After Intraocular Pressure Reduction
During the glaucomatous disease process, subpopulations of cells may be dead, damaged or healthy. Visual function changes could be observed due to a recovering of the suffering ganglion cells after the intraocular pressure reduction. This study aims at evaluating the correlation between intraocular pressure reduction and visual function changes in glaucoma patients after using antiglaucoma medications.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–80 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
About this study
Primary open angle glaucoma patients without use of antiglaucoma medications will be enrolled in this study. After inclusion, the patients will randomly receive one of three antiglaucoma medications (timolol maleate 0,5%, brimonidine tartrate 0,2% or travoprost 0,004%) in one randomly selected eye.
The patients will be evaluated with Goldmann applanation tonometry, visual acuity test, contrast sensitivity test, visual quality perception test (visual analogue scale) and standard automated perimetry before and after 4 weeks of glaucoma treatment onset.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Primary open angle glaucoma
- Intraocular pressure greater than 21 mmHg
Exclusion criteria
- Best corrected visual acuity (BCVA) worse than 20/80
- Significant media opacity
- History of steroid use
Treatment and study plan
brimonidine tartrate 0,2%
Drugtravoprost 0,004%
DrugPrimary outcomes
-
intraocular pressure
-
contrast sensitivity
-
visual quality perception
Secondary outcomes
-
Mean deviation of the visual field (MD)
-
Pattern Standard Deviation of the visual field (PSD)
-
visual acuity
Sponsors and collaborators
Lead sponsor
University of Sao Paulo
Other
Registry information
Official study title
Visual Function Changes After Intraocular Pressure Reduction Using Antiglaucoma Medications: A Randomized Clinical Trial
Important dates
- Study start
- 2005
- Study completion
- 2006
- First posted
- Feb 14, 2007
- Registry last updated
- Feb 19, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Effect of ROCK Inhibitors on Corneas of Patients With Glaucoma and Pseudophakic Bullous Keratopathy (PBK)
NCT06960629
Corneal Diseases, Corneal Edema
Zagreb, Croatia
View Trial DetailsVW-50 Feasibility Study
NCT07730424
Eye Diseases, Glaucoma
Fitzroy, Victoria, Australia
View Trial DetailsPhase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
NCT07168902
Eye Diseases, Glaucoma
Glendale, California, United States
View Trial DetailsAI for the Detection of Retinal Disease and Glaucoma in Patients With Diabetes Mellitus in Primary Care
NCT04132401
Age-Related Macular Degeneration, Cardiovascular Diseases
Manresa, Barcelona, Spain
View Trial Details